0.00
100.00%
-7.539
Finanzdaten der Kintara Therapeutics Inc-Aktie (KTRA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Operating Expenses
|
104.61%
2.085
|
1.019 | 2.962 | 3.349 | 3.302 |
Nonoperating Income/Loss |
1,950%
0.074
|
-0.004 | - | 0.014 | 0.038 |
Income/Loss From Continuing Operations Before Tax |
96.58%
-2.011
|
-1.023 | -2.962 | -3.335 | -3.264 |
Income/Loss From Continuing Operations After Tax |
96.58%
-2.011
|
-1.023 | -2.962 | -3.335 | -3.264 |
Net Income/Loss
|
96.58%
-2.011
|
-1.023 | -2.962 | -3.335 | -3.264 |
Preferred Stock Dividends And Other Adjustments |
0.002
|
- | - | 0.002 | 0.002 |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
927.48%
44.56
|
4.337 | 1.718 | 0.024 | 1.681 |
Basic Earnings Per Share |
79.17%
-0.05
|
-0.24 | -1.83 | -1.95 | -1.94 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
0.002
|
- | - | 0.002 | 0.002 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):